BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 25205638)

  • 1. Low expression of nuclear Toll-like receptor 4 in laryngeal papillomas transforming into squamous cell carcinoma.
    Ilmarinen T; Hagström J; Haglund C; Auvinen E; Leivo I; Pitkäranta A; Aaltonen LM
    Otolaryngol Head Neck Surg; 2014 Nov; 151(5):785-90. PubMed ID: 25205638
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular transformation of recurrent respiratory papillomatosis: viral typing and p53 overexpression.
    Go C; Schwartz MR; Donovan DT
    Ann Otol Rhinol Laryngol; 2003 Apr; 112(4):298-302. PubMed ID: 12731623
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical and molecular biology studies of respiratory papillomatosis].
    Mahnke CG; Werner JA; Fröhlich O; Lippert BM; Hoffmann M; Rudert HH
    Laryngorhinootologie; 1998 Mar; 77(3):157-64. PubMed ID: 9577823
    [TBL] [Abstract][Full Text] [Related]  

  • 4. P53 and PCNA is positively correlated with HPV infection in laryngeal epitheliopapillomatous lesions in patiets with different ethnic backgrounds in Xinjiang.
    Sun J; Xiong J; Zhen Y; Chen ZL; Zhang H
    Asian Pac J Cancer Prev; 2012; 13(11):5439-44. PubMed ID: 23317197
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum matrix metalloproteinase 8 and tissue inhibitor of metalloproteinase 1: Potential markers for malignant transformation of recurrent respiratory papillomatosis and for prognosis of laryngeal cancer.
    Pakkanen PP; Aaltonen LM; Sorsa TA; Tervahartiala TI; Hagström JK; Ilmarinen TT
    Head Neck; 2019 Feb; 41(2):309-314. PubMed ID: 30549356
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protein expression of the tumor suppressors p16INK4A and p53 and disease progression in recurrent respiratory papillomatosis.
    Pham TT; Ongkeko WM; An Y; Yi ES
    Laryngoscope; 2007 Feb; 117(2):253-7. PubMed ID: 17277618
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical and molecular biology studies of laryngeal papillomatosis].
    Mahnke CG; Werner JA; Fröhlich O; Lippert BM; Hoffman H; Rudert HH
    Laryngorhinootologie; 1998 Jan; 77(1):27-33. PubMed ID: 9522309
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biological and clinical significance of p75NTR expression in laryngeal squamous epithelia and laryngocarcinoma.
    Li X; Shen Y; Di B; Li J; Geng J; Lu X; He Z
    Acta Otolaryngol; 2012 Mar; 132(3):314-24. PubMed ID: 22201277
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Malignant degeneration in laryngeal papillomatosis].
    Grøn AL; Schultz JH; Abildgaard J
    Ugeskr Laeger; 2011 Feb; 173(7):506-7. PubMed ID: 21320416
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Presence of HPV type 6 in dysplasia and carcinoma arising from recurrent respiratory papillomatosis.
    Jeong WJ; Park SW; Shin M; Lee YJ; Jeon YK; Jung YH; Hah JH; Kwon TK; Song YS; Kim KH; Sung MW
    Head Neck; 2009 Aug; 31(8):1095-101. PubMed ID: 19072996
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Expression and role of survivin in laryngeal squamous cell carcinoma and laryngeal papilloma in adults].
    Xie H; Zhang B; Yin J; Song F
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2007 May; 21(9):413-6. PubMed ID: 17634026
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Correlation of EphA2 protein expression with clinicopathological characteristics and prognosis in laryngeal squamous cell carcinoma].
    Liu Y; Zhang X; Qiu YZ; Huang DH; Zhou XJ; Tan PQ; Cai GM; Dai YZ; Yu CY; Xiao JY; Tian YQ
    Zhonghua Zhong Liu Za Zhi; 2011 Mar; 33(3):197-201. PubMed ID: 21575519
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Malignant degeneration of juvenile laryngeal papillomatosis?].
    Schick B; Kronsbein H; Heil M; Draf W
    Laryngorhinootologie; 1997 Mar; 76(3):150-4. PubMed ID: 9213403
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Malignant transformation of recurrent respiratory papillomatosis associated with integrated human papillomavirus type 11 DNA and mutation of p53.
    Rady PL; Schnadig VJ; Weiss RL; Hughes TK; Tyring SK
    Laryngoscope; 1998 May; 108(5):735-40. PubMed ID: 9591556
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The expression of SOCS1 and TLR4-NFkappaB pathway molecules in neoplastic cells as potential biomarker for the aggressive tumor phenotype in laryngeal carcinoma.
    Starska K; Forma E; Lewy-Trenda I; Stasikowska O; Bryś M; Krajewska WM; Łukomski M
    Folia Histochem Cytobiol; 2009 Jan; 47(3):401-10. PubMed ID: 20164024
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Bronchopulmonary squamous cell carcinoma associated with HPV 11 in a 15-year-old girl with a history of severe recurrent respiratory papillomatosis: a case report].
    Saumet L; Damay A; Jeziorski E; Cartier C; Rouleau C; Margueritte G; Rodière M; Segondy M
    Arch Pediatr; 2011 Jul; 18(7):754-7. PubMed ID: 21596535
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High incidence of malignant transformation of laryngeal papilloma in Taiwan.
    Lee LA; Cheng AJ; Fang TJ; Huang CG; Liao CT; Chang JT; Li HY
    Laryngoscope; 2008 Jan; 118(1):50-5. PubMed ID: 17975511
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Topoisomerase alpha II, retinoblastoma gene product, and p53: potential relationships with aggressive behavior and malignant transformation in recurrent respiratory papillomatosis.
    Gupta D; Holden J; Layfield L
    Appl Immunohistochem Mol Morphol; 2001 Mar; 9(1):86-91. PubMed ID: 11277421
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Integration of human papillomavirus type 11 in recurrent respiratory papilloma-associated cancer.
    Reidy PM; Dedo HH; Rabah R; Field JB; Mathog RH; Gregoire L; Lancaster WD
    Laryngoscope; 2004 Nov; 114(11):1906-9. PubMed ID: 15510012
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of Cell Cycle-related Proteins p16, p27 and Ki-67 Proliferating Marker in Laryngeal Squamous Cell Carcinomas and in Laryngeal Papillomas.
    Ciesielska U; Zatonski T; Nowinska K; Ratajczak-Wielgomas K; Grzegrzolka J; Piotrowska A; Olbromski M; Pula B; Podhorska-Okolow M; Dziegiel P
    Anticancer Res; 2017 May; 37(5):2407-2415. PubMed ID: 28476808
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.